Aggreko Plc — Director's Dealing 2019

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3798A

Aggreko PLC

28 May 2019

The following amendment has been made to the Headline announcement released on 28 May 2019 at 1552 under RNS Number:  3738A

4b - the date has been changed from 20 October 2018 to 24 May 2019

All other details remain unchanged

28 May 2019

NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES

The notification made on behalf of Persons Discharging Managerial Responsibility ('PDMRs') under article 19.1 of the Market Abuse Regulation ('MAR') relates to a transaction made on behalf of Chris Weston, a PDMR, in Aggreko plc shares.

This announcement is made in accordance with Article 19.3 of MAR

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Chris Weston

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Aggreko plc

b)

LEI

2138003R7TGCSVF27H47

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 4 329/395 pence each ('Shares')

GB00BK1PTB77

b)

Nature of the transaction

Acquisition of Shares under the Aggreko Vested Share Account re-investment plan following the dividend payment on 24 May 2019.

c)

Price(s) and volume(s)

d)

Aggregated information

- Aggregated volume

- Price

1,763

£8.102

e)

Date of the transaction

24 May 2019

f)

Place of the transaction

London Stock Exchange

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHUWSVRKVAVUAR